Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from <i>Terminalia chebula</i>: A Structural Perspective

<i>Terminalia chebula</i> Retz. forms a key component of traditional folk medicine and is also reported to possess antihepatitis C virus (HCV) and immunomodulatory activities. However, information on the intermolecular interactions of phytochemicals from this plant with HCV and human pro...

Full description

Bibliographic Details
Main Authors: Vishal S. Patil, Darasaguppe R. Harish, Umashankar Vetrivel, Subarna Roy, Sanjay H. Deshpande, Harsha V. Hegde
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/27/3/1076
_version_ 1797485949988372480
author Vishal S. Patil
Darasaguppe R. Harish
Umashankar Vetrivel
Subarna Roy
Sanjay H. Deshpande
Harsha V. Hegde
author_facet Vishal S. Patil
Darasaguppe R. Harish
Umashankar Vetrivel
Subarna Roy
Sanjay H. Deshpande
Harsha V. Hegde
author_sort Vishal S. Patil
collection DOAJ
description <i>Terminalia chebula</i> Retz. forms a key component of traditional folk medicine and is also reported to possess antihepatitis C virus (HCV) and immunomodulatory activities. However, information on the intermolecular interactions of phytochemicals from this plant with HCV and human proteins are yet to be established. Thus, by this current study, we investigated the HCV NS3/4A inhibitory and host immune-modulatory activity of phytocompounds from <i>T. chebula</i> through in silico strategies involving network pharmacology and structural bioinformatics techniques. To start with, the phytochemical dataset of <i>T. chebula</i> was curated from biological databases and the published literature. Further, the target ability of the phytocompounds was predicted using BindingDB for both HCV NS3/4A and other probable host targets involved in the immune system. Further, the identified targets were docked to the phytochemical dataset using AutoDock Vina executed through the POAP pipeline. The resultant docked complexes with significant binding energy were subjected to 50 ns molecular dynamics (MD) simulation in order to infer the stability of complex formation. During network pharmacology analysis, the gene set pathway enrichment of host targets was performed using the STRING and Reactome pathway databases. Further, the biological network among compounds, proteins, and pathways was constructed using Cytoscape 3.6.1. Furthermore, the druglikeness, side effects, and toxicity of the phytocompounds were also predicted using the MolSoft, ADVERpred, and PreADMET methods, respectively. Out of 41 selected compounds, 10 were predicted to target HCV NS3/4A and also to possess druglike and nontoxic properties. Among these 10 molecules, Chebulagic acid and 1,2,3,4,6-Pentagalloyl glucose exhibited potent HCV NS3/4A inhibitory activity, as these scored a lowest binding energy (BE) of −8.6 kcal/mol and −7.7 kcal/mol with 11 and 20 intermolecular interactions with active site residues, respectively. These findings are highly comparable with Asunaprevir (known inhibitor of HCV NS3/4A), which scored a BE of −7.4 kcal/mol with 20 key intermolecular interactions. MD studies also strongly suggest that chebulagic acid and 1,2,3,4,6-Pentagalloyl glucose as promising leads, as these molecules showed stable binding during 50 ns of production run. Further, the gene set enrichment and network analysis of 18 protein targets prioritized 10 compounds and were predicted to potentially modulate the host immune system, hemostasis, cytokine levels, interleukins signaling pathways, and platelet aggregation. On overall analysis, this present study predicts that tannins from <i>T. chebula</i> have a potential HCV NS3/4A inhibitory and host immune-modulatory activity. However, further experimental studies are required to confirm the efficacies.
first_indexed 2024-03-09T23:26:11Z
format Article
id doaj.art-41c89af346bf4bb3b7df63d5ddbb5a42
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-09T23:26:11Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-41c89af346bf4bb3b7df63d5ddbb5a422023-11-23T17:17:13ZengMDPI AGMolecules1420-30492022-02-01273107610.3390/molecules27031076Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from <i>Terminalia chebula</i>: A Structural PerspectiveVishal S. Patil0Darasaguppe R. Harish1Umashankar Vetrivel2Subarna Roy3Sanjay H. Deshpande4Harsha V. Hegde5ICMR-National Institute of Traditional Medicine, Nehru Nagar, Belagavi 590010, IndiaICMR-National Institute of Traditional Medicine, Nehru Nagar, Belagavi 590010, IndiaICMR-National Institute of Traditional Medicine, Nehru Nagar, Belagavi 590010, IndiaICMR-National Institute of Traditional Medicine, Nehru Nagar, Belagavi 590010, IndiaICMR-National Institute of Traditional Medicine, Nehru Nagar, Belagavi 590010, IndiaICMR-National Institute of Traditional Medicine, Nehru Nagar, Belagavi 590010, India<i>Terminalia chebula</i> Retz. forms a key component of traditional folk medicine and is also reported to possess antihepatitis C virus (HCV) and immunomodulatory activities. However, information on the intermolecular interactions of phytochemicals from this plant with HCV and human proteins are yet to be established. Thus, by this current study, we investigated the HCV NS3/4A inhibitory and host immune-modulatory activity of phytocompounds from <i>T. chebula</i> through in silico strategies involving network pharmacology and structural bioinformatics techniques. To start with, the phytochemical dataset of <i>T. chebula</i> was curated from biological databases and the published literature. Further, the target ability of the phytocompounds was predicted using BindingDB for both HCV NS3/4A and other probable host targets involved in the immune system. Further, the identified targets were docked to the phytochemical dataset using AutoDock Vina executed through the POAP pipeline. The resultant docked complexes with significant binding energy were subjected to 50 ns molecular dynamics (MD) simulation in order to infer the stability of complex formation. During network pharmacology analysis, the gene set pathway enrichment of host targets was performed using the STRING and Reactome pathway databases. Further, the biological network among compounds, proteins, and pathways was constructed using Cytoscape 3.6.1. Furthermore, the druglikeness, side effects, and toxicity of the phytocompounds were also predicted using the MolSoft, ADVERpred, and PreADMET methods, respectively. Out of 41 selected compounds, 10 were predicted to target HCV NS3/4A and also to possess druglike and nontoxic properties. Among these 10 molecules, Chebulagic acid and 1,2,3,4,6-Pentagalloyl glucose exhibited potent HCV NS3/4A inhibitory activity, as these scored a lowest binding energy (BE) of −8.6 kcal/mol and −7.7 kcal/mol with 11 and 20 intermolecular interactions with active site residues, respectively. These findings are highly comparable with Asunaprevir (known inhibitor of HCV NS3/4A), which scored a BE of −7.4 kcal/mol with 20 key intermolecular interactions. MD studies also strongly suggest that chebulagic acid and 1,2,3,4,6-Pentagalloyl glucose as promising leads, as these molecules showed stable binding during 50 ns of production run. Further, the gene set enrichment and network analysis of 18 protein targets prioritized 10 compounds and were predicted to potentially modulate the host immune system, hemostasis, cytokine levels, interleukins signaling pathways, and platelet aggregation. On overall analysis, this present study predicts that tannins from <i>T. chebula</i> have a potential HCV NS3/4A inhibitory and host immune-modulatory activity. However, further experimental studies are required to confirm the efficacies.https://www.mdpi.com/1420-3049/27/3/10761,2,3,4,6-Pentagalloyl glucosechebulagic aciddockingdynamicshepatitis C virus NS3/4Anetwork pharmacology
spellingShingle Vishal S. Patil
Darasaguppe R. Harish
Umashankar Vetrivel
Subarna Roy
Sanjay H. Deshpande
Harsha V. Hegde
Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from <i>Terminalia chebula</i>: A Structural Perspective
Molecules
1,2,3,4,6-Pentagalloyl glucose
chebulagic acid
docking
dynamics
hepatitis C virus NS3/4A
network pharmacology
title Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from <i>Terminalia chebula</i>: A Structural Perspective
title_full Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from <i>Terminalia chebula</i>: A Structural Perspective
title_fullStr Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from <i>Terminalia chebula</i>: A Structural Perspective
title_full_unstemmed Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from <i>Terminalia chebula</i>: A Structural Perspective
title_short Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from <i>Terminalia chebula</i>: A Structural Perspective
title_sort hepatitis c virus ns3 4a inhibition and host immunomodulation by tannins from i terminalia chebula i a structural perspective
topic 1,2,3,4,6-Pentagalloyl glucose
chebulagic acid
docking
dynamics
hepatitis C virus NS3/4A
network pharmacology
url https://www.mdpi.com/1420-3049/27/3/1076
work_keys_str_mv AT vishalspatil hepatitiscvirusns34ainhibitionandhostimmunomodulationbytanninsfromiterminaliachebulaiastructuralperspective
AT darasagupperharish hepatitiscvirusns34ainhibitionandhostimmunomodulationbytanninsfromiterminaliachebulaiastructuralperspective
AT umashankarvetrivel hepatitiscvirusns34ainhibitionandhostimmunomodulationbytanninsfromiterminaliachebulaiastructuralperspective
AT subarnaroy hepatitiscvirusns34ainhibitionandhostimmunomodulationbytanninsfromiterminaliachebulaiastructuralperspective
AT sanjayhdeshpande hepatitiscvirusns34ainhibitionandhostimmunomodulationbytanninsfromiterminaliachebulaiastructuralperspective
AT harshavhegde hepatitiscvirusns34ainhibitionandhostimmunomodulationbytanninsfromiterminaliachebulaiastructuralperspective